Atis Dry Extract is a botanical ingredient associated with Aconitum heterophyllum Wall. ex Royle, a plant belonging to the Ranunculaceae family. Commonly known as Atis, Atees, or Ativisha, this medicinal plant has a documented history in traditional Indian systems of medicine.
The plant's dried tuberous roots are traditionally used as the botanical raw material. A dry extract is prepared by processing plant material through an appropriate extraction and drying process. Its final characteristics depend on botanical identity, plant part, extraction solvent, processing conditions, and the manufacturer's specifications.
Aconitum heterophyllum has been investigated for its naturally occurring diterpenoid alkaloids, including atisine and related compounds. The chemical profile of a commercial dry extract depends on the raw material and extraction process. The presence and concentration of individual compounds should be established through appropriate analytical testing.
The composition of Atis Dry Extract should not be assumed to be identical across different suppliers or batches. A product-specific Certificate of Analysis (CoA) is necessary to confirm its identity, composition, and quality parameters.
Botanical dry extracts are generally produced through raw material identification, cleaning, preparation, extraction, separation, concentration, and drying. The actual manufacturing process for Atis Dry Extract should be documented by the manufacturer.
The extraction solvent, extraction ratio, drying method, and any standardization requirements should be recorded in the technical documentation. These factors can influence the composition and quality of the finished ingredient.
Quality assessment should be based on a documented specification and batch-specific testing. Depending on the product and intended application, relevant parameters may include botanical identification, appearance, moisture content, ash values, marker-compound analysis, heavy metals, microbiological quality, and residual solvents.
Acceptance limits should be established using the applicable product specification and regulatory requirements. Exact assay values and other technical parameters must be verified before publication.
Atis belongs to the genus Aconitum, which includes species containing potentially toxic alkaloids. Although Aconitum heterophyllum has a different alkaloid profile from certain highly toxic species in the genus, the safety of a commercial extract cannot be inferred from its botanical name alone.
Correct species identification, appropriate processing, contaminant testing, and product-specific safety evaluation are essential. The extract should not be promoted for self-medication or disease treatment without suitable evidence and regulatory authorization.
Before commercial approval, buyers should confirm the botanical identity, plant part, extraction method, product grade, assay or marker specification, safety documentation, packaging, storage conditions, and applicable regulatory status.
Mediocon Inc. product information should be updated using verified supplier or manufacturer records. Product availability, manufacturing status, certifications, and exact technical specifications should be confirmed before publication.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Atis Dry Extract Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Atis Dry Extract Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance